AR

Ashish Ranjan

Active Director Director DIN 08825924
DIN 08825924 First appointment Aug 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Ashish Ranjan

Data last updated:

Ashish Ranjan is a Director at Momnext Pharma Private Limited (since 2020). The company operates in Trading. Momnext Pharma Private Limited reported revenue of ₹17.7 Lakh (FY 2024).

DIN 08825924
Primary Designation Director
Industry Trading
First Appointment 11 Aug 2020
Oldest Company Age 6 yrs
Largest company Momnext Pharma Private Limited · ₹17.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Momnext Pharma Private Limited U51909UP2020PTC132531
Director11 Aug 20202020₹17.7 Lakh (FY 2024)Active

Board colleagues of Ashish Ranjan

NameDINCompanyDesignation
Sweta Bharti08825955Momnext Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Momnext Pharma Private Limited
Premium access

Shareholding and investment profile for Ashish Ranjan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashish Ranjan

Ashish Ranjan currently holds 1 directorship: Momnext Pharma Private Limited (Director, since 11 Aug 2020, revenue ₹17.7 Lakh (FY 2024)).

Ashish Ranjan was first appointed on 11 Aug 2020 as Director at Momnext Pharma Private Limited.

The current boards of Ashish Ranjan's companies include Sweta Bharti (Momnext Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available